Pacira Pharma (PCRX) Misses Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Join SI Premium – FREE
Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of ($0.19), $0.15 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $69.3 million versus the consensus estimate of $70.24 million.
For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
